Monte Rosa Therapeutics, Inc. (GLUE) vs SL Science Holding Ltd (SLBT)
A side-by-side comparison of Monte Rosa Therapeutics, Inc. and SL Science Holding Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GLUE
Monte Rosa Therapeutics, Inc.
$9.88HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT
SLBT
SL Science Holding Ltd
$1.52HealthcareDelayed quote: Oct 6, 2026, 2:35 PM EDT
Total return — GLUE vs SLBT
growth of $100 · dividends reinvested · last 1yGLUE -43.4% (-43.4%/yr)SLBT -79.6% (-79.6%/yr)GLUE compounded faster over this window
GLUE SLBT
GLUE vs SLBT: by the numbers
- •SLBT is the larger company ($852M vs $835M market cap).
- •Both run net losses; SLBT's is the smaller (-173.85% vs -560.85% net margin).
Metrics side by side
Valuation
| Metric | GLUE | SLBT |
|---|---|---|
| P/S ratio | 29.05 | N/A |
| P/B ratio | 1.71 | 373.20 |
Profitability
| Metric | GLUE | SLBT |
|---|---|---|
| Gross margin | 92.94% | 35.27% |
| Operating margin | -43.83% | -174.65% |
| Net margin | -560.85% | -173.85% |
| ROE | -33.06% | -167.25% |
| ROIC | -28.69% | -163.39% |
Growth (annualized)
| Metric | GLUE | SLBT |
|---|---|---|
| Total return CAGR (5Y) | -12.32% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.